KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to 0.25%.

  • Resmed's Return on Capital Employed rose 100.0% to 0.25% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.25%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.26% for FY2025, which is 400.0% up from last year.
  • Latest data reveals that Resmed reported Return on Capital Employed of 0.25% as of Q4 2025, which was up 100.0% from 0.25% recorded in Q3 2025.
  • In the past 5 years, Resmed's Return on Capital Employed ranged from a high of 0.25% in Q4 2025 and a low of 0.19% during Q1 2023
  • For the 5-year period, Resmed's Return on Capital Employed averaged around 0.23%, with its median value being 0.23% (2021).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 600bps in 2021, then crashed by -500bps in 2023.
  • Quarter analysis of 5 years shows Resmed's Return on Capital Employed stood at 0.24% in 2021, then decreased by -15bps to 0.2% in 2022, then dropped by -7bps to 0.19% in 2023, then soared by 31bps to 0.25% in 2024, then grew by 3bps to 0.25% in 2025.
  • Its last three reported values are 0.25% in Q4 2025, 0.25% for Q3 2025, and 0.25% during Q2 2025.